You might want to take a look at Hims & Hers Health Inc (HIMS) now

With 59.18 million shares changed hands, the volume of the stock remained heavier than its average volume of 14.74 million shares. The 52-week range on HIMS shows that it touched its highest point at $64.84 and its lowest point at $9.22 during that stretch. It currently has a 1-year price target of $35.33. Beta for the stock currently stands at 1.41.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HIMS was up-trending over the past week, with a rise of 57.73%, but this was up by 146.82% over a month. Three-month performance surged to 229.69% while six-month performance rose 341.21%. The stock gained 583.98% in the past year, while it has gained 184.28% so far this year. A look at the trailing 12-month EPS for HIMS yields 0.43 with Next year EPS estimates of 0.53. For the next quarter, that number is 0.11. This implies an EPS growth rate of 589.94% for this year and -1.75% for next year.

Float and Shares Shorts:

At present, 209.44 million HIMS shares are outstanding with a float of 178.10 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HIMS since 13 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.58193 being high and $0.50303 being low. For HIMS, this leads to a yearly average estimate of $0.54248. Based on analyst estimates, the high estimate for the next quarter is $0.24 and the low estimate is $0.19. The average estimate for the next quarter is thus $0.22.